The SAB was enthusiastic about our candidate V4C232 as new treatment in cirrhotic refractory ascites* and confirmed there is no new other therapeutic option, so far. SAB agreed with the proposal of V4CURE to consider the refractory ascites definition previously used in clinical trial. (*) Definition of diuretic-resistant refractory ascites: ascites that cannot be mobilized or...Read More
Recent Comments